Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.
Saved in:
| Title: | Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin. |
|---|---|
| Authors: | Falkson CI; Department of Medical Oncology, University of Pretoria, Republic of South Africa. cfalkson@medic.up.ac.za, Cohen GL |
| Source: | Oncology [Oncology] 1998 Mar-Apr; Vol. 55 (2), pp. 116-21. |
| Publication Type: | Clinical Trial; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
